Advanced company searchLink opens in new window

OMASS THERAPEUTICS LIMITED

Company number 10028228

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
09 Oct 2018 PSC05 Change of details for Syncona Limited as a person with significant control on 11 September 2018
25 Sep 2018 PSC02 Notification of Syncona Limited as a person with significant control on 11 September 2018
25 Sep 2018 PSC07 Cessation of Oxford Sciences Innovation Plc as a person with significant control on 11 September 2018
11 Sep 2018 SH01 Statement of capital following an allotment of shares on 29 June 2018
  • GBP 7,232.265
02 Aug 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
18 Jul 2018 TM01 Termination of appointment of William Graham Richards as a director on 28 June 2018
18 Jul 2018 TM01 Termination of appointment of David John Brister as a director on 28 June 2018
17 Jul 2018 AP01 Appointment of Mr Edward Eliot Hodgkin as a director on 24 May 2017
17 Jul 2018 AP01 Appointment of Dr Magdalena Anna Jonikas as a director on 29 June 2018
01 Jun 2018 TM02 Termination of appointment of Roger James Humm as a secretary on 31 March 2018
01 Jun 2018 TM01 Termination of appointment of Roger James Humm as a director on 31 March 2018
23 Apr 2018 AA Total exemption full accounts made up to 31 December 2017
08 Mar 2018 CS01 Confirmation statement made on 25 February 2018 with updates
10 Aug 2017 AA Total exemption full accounts made up to 31 December 2016
13 Jun 2017 AP01 Appointment of Mr David John Brister as a director on 24 May 2017
21 Apr 2017 SH01 Statement of capital following an allotment of shares on 29 March 2017
  • GBP 3,165.513
08 Mar 2017 CS01 Confirmation statement made on 25 February 2017 with updates
04 Oct 2016 AD01 Registered office address changed from C/O James Cowper Kreston 2 Chawley Park Cumnor Hill Oxford Oxfordshire OX2 9GG England to Centre for Innovation & Enterprise Begbroke Science Park, Begbroke Hill Begbroke Oxford OX5 1PF on 4 October 2016
12 May 2016 SH01 Statement of capital following an allotment of shares on 24 March 2016
  • GBP 2,078.877
12 May 2016 SH01 Statement of capital following an allotment of shares on 24 March 2016
  • GBP 3,078.877
11 May 2016 SH01 Statement of capital following an allotment of shares on 22 March 2016
  • GBP 2,000
11 May 2016 SH01 Statement of capital following an allotment of shares on 22 March 2016
  • GBP 1,500
11 May 2016 SH01 Statement of capital following an allotment of shares on 22 March 2016
  • GBP 1,000
08 Apr 2016 AP01 Appointment of Professor William Graham Richards as a director on 1 April 2016
06 Apr 2016 AA01 Current accounting period shortened from 28 February 2017 to 31 December 2016